MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • 2019 International Congress

    Atypical presentation of Dopa-responsive dystonia- late onset with severe swallowing difficulty

    C. Zhao, L. Li, H. Li, J. Zhang (Jinan, China)

    Objective: To learn about atypical presentation of Dopa-responsive dystonia (DRD) and give correct diagnose in time. Background: DRD compasses a group of clinically and genetically…
  • 2019 International Congress

    Clinical Profile and Response to EMG-Guided Botulinum toxin (BTX) Injection in Writers’ Cramp (WC)- A Study of 25 Indian Patients

    P. Agarwal, P. Palekar (Mumbai, India)

    Objective: To study WC and its response to EMG-Guided BTX Background: Despite decades of use and popularity of BTX in WC, there is a paucity of…
  • 2019 International Congress

    Quality of life in isolated dystonia – a cross-sectional study

    J. Junker, B. Berman, D. Wahba, J. Hall, J. Perlmutter, J. Jankovic, I. Malaty, V. Brandt, S. Reich, A. Espay, N. Patel, E. Roze, M. Vidailhet, H. Jinnah, N. Brueggemann (Luebeck, Germany)

    Objective: To evaluate the relationship between health-related quality of life (HR-QoL) and both physical and psychiatric factors in a large, international, multi-centre cohort of isolated…
  • 2019 International Congress

    Task Specific Dystonia and Its Response to Botulinum Neurotoxin Treatment

    R. Ortiz, T. Mertsalmi, F. Scheperjans, E. Pekkonen (Helsinki, Finland)

    Objective: To study the clinical features in task specific dystonia and its response to botulinum neurotoxin (BoNT) treatment. Background: Task specific dystonia is rare form…
  • 2019 International Congress

    Dystonic versus parkinsonian tremor

    J. Svantnerova, Z. Kosutzka, M. Minar (Bratislava, Slovakia)

    Objective: To present cases of patients with diagnostic uncertainty between tremor in Parkinson’s disease (PD) and dystonic tremor. Background: Some patients with clinical presentation of…
  • 2019 International Congress

    Development of a questionnaire to assess sensory trick in patients with dystonia

    L. Avanzino, G. Bonassi, N. Cothros, E. Pelosin, R. Marchese, G. Abbruzzese, F. Morgante, D. Martino (Genova, Italy)

    Objective: We developed an ad hoc questionnaire detailing sensory trick information, in order to classify the most used tricks, their frequency and their efficacy to…
  • 2019 International Congress

    Predictors of quality of life in dystonia – a longitudinal study

    J. Junker, J. Hall, B. Berman, M. Vidailhet, E. Roze, I. Malaty, J. Jankovic, S. Reich, A. Espay, N. Patel, J. Perlmutter, H. Jinnah, V. Brandt, N. Brueggemann (Luebeck, Germany)

    Objective: To determine the impact of physical and psychiatric morbidity on health-related quality of life (HR-QoL) in a large, international, multi-centre cohort of isolated dystonia…
  • 2019 International Congress

    Drug-induced dystonia

    JB. Paredes, V. Hristova, J. Poles, S. Madrona, P. Torre, I. Moreno, S. Argos, A. Canovas, JC. Castrillo, JL. Moreno (Madrid, Spain)

    Objective: A systematic review of patients treated in the emergency department of a tertiary referral hospital for acute dystonic reactions Background: The dystonias are characterised…
  • 2019 International Congress

    Movement disorders in neurologic consultation of Marrakesh University Hospital

    L. Berrhoute, J. El Mesbahy, N. Kissani (Marrakesh, Morocco)

    Objective: Describing the epidemiological and clinical aspects of the movement’s disorders in Marrakesh. Analyzing difficulties of management of this disease. Comparing our data with international…
  • 2019 International Congress

    How Commonly Does Parkinson’s Disease Present with Dystonia?

    P. Popa, C. Brown, C. Henchcliffe, H. Sarva (New York, NY, USA)

    Objective: To review dystonia as the presenting feature of Parkinson’s disease (PD). Background: Dystonia in PD is most commonly described as a levodopa complication. It…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 48
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley